Cardiovascular risk in type 2 diabetes patients

Cardiovascular risk in type 2 diabetes patients

Cardiovascular diseases remain leading cause of high mortality in diabetes patients. The article is focused on the influence of diabetes on cardiovascular risks. The prevalence presented, as the significance of the main and additional risk factors of cardiovascular diseases in the development of mac...

Full description

Bibliographic Details
Main Authors:	O. D. Ostroumova, I. V. Goloborodova, V. М. Fomina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2018-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	diabetes mellitus cardiovascular risk arterial hypertension dyslipidemia obesity anti-diabetic therapy dapagliflozin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/848

Similar Items

Control of cardiovascular risk in patients with diabetes
by: Zhernakova Yu.V., et al.
Published: (2016-08-01)

Control of cardiovascular risk in patients with diabetes
by: Yu V Zhernakova, et al.
Published: (2016-09-01)

Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India
by: Kamlesh Kumar Gupta, et al.
Published: (2017-05-01)

Effect of dapagliflozin on the structural and functional properties of arterial vessels in patients with type 2 diabetes mellitus in combination with obesity
by: О. А. Soloviuk, et al.
Published: (2020-12-01)

Metabolic Alterations, Aggressive Hormone-Naïve Prostate Cancer and Cardiovascular Disease: A Complex Relationship
by: Simona Di Francesco, et al.
Published: (2019-03-01)

Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
by: Eun-Jung Rhee
Published: (2020-03-01)

Practice of Dapagliflozin Application in Patients with Type 2 Diabetes Mellitus
by: L.V. Shkala, et al.
Published: (2015-08-01)

Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study
by: Fumika Shigiyama, et al.
Published: (2018-06-01)

Hypertension is the Prominent Risk Factor in Cataract Patients
by: Ioanna Mylona, et al.
Published: (2019-08-01)

Control of blood pressure and cardiovascular outcomes in type 2 diabetes
by: Vargas-Uricoechea Hernando, et al.
Published: (2018-08-01)

Cardiovascular Risk Factors in Young Patients of Coronary ArteryDisease: Differences over a Decade
by: Amitesh Aggarwal, et al.
Published: (2014-10-01)

Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease
by: Namita Mahalle, et al.
Published: (2014-01-01)

The impact of environmental cadmium exposure on type 2 diabetes risk: a protocol for an overview of systematic reviews
by: Julia Hildebrand, et al.
Published: (2019-12-01)

The prevalence of major cardiovascular risk factors in a rural population of the Chui region of Kyrgyzstan: The results of an epidemiological study
by: Andrey G Polupanov, et al.
Published: (2020-08-01)

Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease
by: Mee Kyoung Kim, et al.
Published: (2019-10-01)

Type 2 diabetes: basic clinical and laboratory parameters and risk of cardiovascular death
by: O D Rymar, et al.
Published: (2020-05-01)

Dyslipidemia in type 2 diabetes mellitus
by: Stefanović Aleksandra, et al.
Published: (2019-01-01)

The Role of Essential Oils and Their Main Compounds in the Management of Cardiovascular Disease Risk Factors
by: Jorge M. Alves-Silva, et al.
Published: (2021-06-01)

Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia
by: Youhyun Song, et al.
Published: (2021-02-01)

Relationship between Sleep Duration and Risk Factors for Stroke
by: Chun Seng Phua, et al.
Published: (2017-08-01)

Findings from Community-Based Screenings for Type 2 Diabetes Mellitus in at Risk Communities in Cape Town, South Africa: A Pilot Study
by: Jillian Hill, et al.
Published: (2020-04-01)

Andrographolide, a New Hope in the Prevention and Treatment of Metabolic Syndrome
by: Muhammad T. Islam, et al.
Published: (2017-08-01)

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
by: Avgerinos I, et al.
Published: (2019-12-01)

Dyslipidemia in young patients with type 1 diabetes mellitus
by: Thaís Kataoka Homma, et al.

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
by: Juliya V Zhernakova, et al.
Published: (2019-09-01)

A Review on the Protective Effects of Honey against Metabolic Syndrome
by: Nur Zuliani Ramli, et al.
Published: (2018-08-01)

Adiposity contributes to poor glycemic control in people with diabetes mellitus, a randomized case study, in South Kashmir, India
by: Gowher Ahmad Wagai, et al.
Published: (2020-01-01)

Dyslipidaemia is common among patients with type 2 diabetes: a cross-sectional study at Tema Port Clinic
by: Emmanuel Kwaku Ofori, et al.
Published: (2019-04-01)

Therapeutic education of patients with Type 2 diabetes mellitus and high cardiovascular risk
by: E. A. Palferova, et al.
Published: (2007-12-01)

ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk inde pendently of baseline blood pressure
by: I. E. Chazova
Published: (2008-04-01)

Relationship between vitamin D status, glycemic control and cardiovascular risk factors in Brazilians with type 2 diabetes mellitus
by: Maria Creusa Rolim, et al.
Published: (2016-11-01)

Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment
by: Stephen Chu-Sung Hu, et al.
Published: (2017-10-01)

Reducing high risk of cardiovascular events in Type 2 diabetes mellitus: DIALOG Study results
by: I. E. Sapozhnikova, et al.
Published: (1970-01-01)

Association of Retinol Binding Protein- 4 (RBP4) with Glycemia, Dyslipidemia, Hypertension, and Obesity in Type 2 Diabetic Iraqi Patients
by: Thair L. Jabbar, et al.
Published: (2020-12-01)

Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes
by: Jin Bong Choi, et al.
Published: (2020-03-01)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
by: Ayman Ibrahim, et al.
Published: (2020-12-01)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
by: Olga Yuryevna Sukhareva, et al.
Published: (2016-01-01)

Plant-Derived Oleanolic Acid (OA) Ameliorates Risk Factors of Cardiovascular Diseases in a Diet-Induced Pre-Diabetic Rat Model: Effects on Selected Cardiovascular Risk Factors
by: Mlindeli Gamede, et al.
Published: (2019-01-01)

Potential Association of Hypothyroidism and Cardiovascular Disorders among Type II Diabetes Mellitus Patients Visiting for Dental Treatment
by: Shantala Arunkumar, et al.
Published: (2017-04-01)

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice
by: M. M. Loukianov, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_35as1n4norkioksq6dpbvbsuo8